Establishing secure connection…Loading editor…Preparing document…

Employee Drug Policy Consent

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

EMPLOYEE DRUG POLICY CONSENT

Personal Information

Position Information

Employment History

Employer 1 — Company Name:

Employer 2 — Company Name:

Education

References

Reference 1

Reference 2

Reference 3

Drug Testing Policy — Acknowledgment and Consent

Purpose: The Employer maintains a drug and alcohol testing policy to provide a safe workplace, to ensure compliance with safety-sensitive duties, and to protect employees, customers, and property. Testing may be conducted in accordance with the Employer's written policy and applicable law.

Types of testing: I acknowledge that testing may be required under any of the following circumstances as set forth in the written policy: pre-employment, reasonable suspicion, post-accident, random selection, return-to-duty, and follow-up testing. By checking consent below, I authorize such testing in accordance with company policy.

Prohibited conduct: The use, sale, distribution, or possession of illegal drugs or the misuse of prescription medication while on duty, on Company premises, or in Company vehicles is strictly prohibited. A confirmed positive test result, refusal to test, adulteration, or tampering with a specimen will subject the employee to disciplinary action up to and including termination, consistent with applicable law and policy.

Medical review and confidentiality: Test results will be reported to a designated Medical Review Officer or other qualified reviewer. Test records and related health information will be maintained in a secure, confidential file and disclosed only as required for legitimate business purposes, for legal compliance, or with my express written authorization.

Legal Disclosures

At-Will Employment: Nothing in this consent or the Employer's drug testing policy alters the at-will employment relationship between the Employer and employee where applicable. Either the Employer or the employee may terminate the employment relationship at any time, with or without cause, subject to any applicable law or written agreement.

Equal Opportunity: The Employer provides equal employment opportunities and will not discriminate on the basis of protected characteristics. Drug testing and disciplinary actions will be applied in a nondiscriminatory manner and in compliance with applicable legislation governing disabilities and medical conditions.

Employee Certification and Authorization

I certify that the information provided on this form is true and complete to the best of my knowledge. I understand that any material misrepresentation, omission, or failure to disclose may result in withdrawal of the employment offer or disciplinary action up to and including termination.

By signing below I acknowledge that I have received or been provided access to the Employer's drug and alcohol testing policy, that I understand the policy, and that I voluntarily consent to the collection and testing of specimens in accordance with that policy and applicable law.

Additional Employee Statement (Optional)

Employee Name:

Signature:

Date:

Enter text✕

What the Employee Drug Policy Consent Is

An Employee Drug Policy Consent is a written acknowledgment that an employee or applicant signs to authorize drug and alcohol testing, to confirm receipt of the employer's testing policy, and to accept testing procedures and consequences. The form typically explains testing types (pre-employment, random, reasonable suspicion, post-incident), sample collection methods, chain-of-custody handling, and how results will be used in personnel decisions. When executed properly, the consent document helps demonstrate informed agreement and supports compliance with workplace safety and privacy obligations.

Why a Clear Consent Form Matters

A properly drafted Employee Drug Policy Consent documents informed agreement, reduces legal exposure, and clarifies testing procedures and confidentiality protections.

Why a Clear Consent Form Matters

Who prepares and signs this consent

Employers, HR teams, safety managers, and hiring departments commonly issue and collect drug policy consent forms before testing or as part of onboarding.

  • Employers and HR departments use the form to document policy acceptance and testing authorization for employees and applicants.
  • Occupational health providers collect consent as part of specimen collection and chain-of-custody procedures for laboratory testing.
  • Legal and compliance teams retain signed consents to support disciplinary actions or defend employment decisions in disputes.

Signed consents are evidence of notice and consent, help meet regulatory safeguards, and should be stored securely according to applicable retention rules.

Typical signers and administrators

HR Manager

Human resources professionals prepare the consent, ensure policy distribution, verify signatures, coordinate testing logistics, and retain records. They balance workplace-safety needs with privacy and ensure the form aligns with federal and state law.

Employee / Applicant

The individual signs to authorize testing and acknowledge policy terms. Their signature demonstrates intent and consent; mismatched or missing signatures can compromise downstream disciplinary or medical-release actions.

Core parts of a professional consent form

A comprehensive Employee Drug Policy Consent includes clear scope, testing types, data handling, consequences, signatures, and legal notices to ensure enforceability and transparency.

Policy Scope

Define covered persons, roles, and which tests (pre-employment, random, post-incident) are authorized and why they apply.

Testing Procedures

Describe specimen types, collection steps, chain-of-custody, and laboratory confirmation processes to avoid disputes about sample integrity.

Use of Results

State how results affect employment decisions, confidentiality limits, and who will receive result notifications.

Privacy Notice

Explain medical-record treatment, who maintains records, and any HIPAA-related safeguards or local privacy requirements.

Consent Language

Include explicit authorization wording, signature block, date, and any options to withdraw consent where applicable.

Acknowledgements

Space for employee initials on key points (testing types, consequences, specimen handling) to confirm understanding.

Step-by-step: completing and storing the consent

Follow these sequential steps to collect a valid Employee Drug Policy Consent and maintain compliance.

  • 01
    Prepare Form: Use employer letterhead and up-to-date policy language.
  • 02
    Provide Notice: Give employee time to review before signing.
  • 03
    Capture Signature: Obtain dated signature (wet or compliant e-signature).
  • 04
    Store Securely: Retain in restricted HR records with access controls.

Digital workflow settings to support consent collection

Configure your e-sign and document workflow to ensure authentication, chain-of-custody tracking, and secure storage.

Field Configuration
Authentication Email link plus optional SMS code or ID verification
Signature Type Allow typed or drawn e-signatures; require audit trail
Chain-of-Custody Lock PDF after signing; capture timestamps and IP
Storage Encrypt at rest and restrict HR access

Typical process from consent to result

This flow outlines key handoffs from consent through specimen collection and result reporting.

  • Issue Consent: Employer provides policy and consent form before testing.
  • Sign and Verify: Employee signs; verifier confirms identity and date.
  • Collect Sample: Certified collector follows chain-of-custody protocol.
  • Report Results: Laboratory returns results to designated medical reviewer.

Technical and integration considerations

Choose an e-sign platform that supports audit trails, secure storage, and common integrations for HR systems.

  • File Formats: PDF and DOCX accepted
  • Integrations: Enable HRIS and cloud storage connectors
  • Authentication: Support email, SMS, and advanced ID checks

Ensure the platform can produce a certificate of completion, preserve a tamper-evident copy, and meet applicable compliance controls.

Typical eSignature vendor pricing and compliance overview

When selecting an eSignature provider for Employee Drug Policy Consent workflows, compare price, trial availability, bulk features, HIPAA support, and envelope limits.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes No
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

How organizations use the consent form in practice

These examples show common, real-world implementations of Employee Drug Policy Consents.

Safety-First Employer

An industrial contractor integrated consent into onboarding to require pre-employment testing.

  • The program used chain-of-custody forms for each specimen.
  • Signed consents and locked test reports reduced disputes and streamlined return-to-work decisions while preserving evidence for OSHA or insurance reviews.

Healthcare Clinic

A multi-site clinic added HIPAA language to consents for employee testing.

  • Medical reviewer workflow was specified for positive results.
  • Combining explicit privacy notices with limited result sharing preserved patient-employee confidentiality and met facility credentialing requirements.

Key security and compliance controls to include

Encryption: TLS 1.2/1.3; AES-256 at rest
Audit Trail: Tamper-evident timestamps and activity logs
Access Controls: Role-based HR access only
BAA Availability: Business Associate Agreement required
Certifications: SOC 2 Type II; ISO 27001
Retention Policy: Secure deletion and legal holds supported

Time-sensitive steps and typical deadlines

Meet timing requirements for notice, testing, and result handling to reduce legal risk and ensure reliable evidence.

Provide Policy Before Testing:

Employee should receive policy and consent before any specimen collection.

Specimen Chain-of-Custody:

Collector documents chain-of-custody at collection time; maintain continuous records.

Lab Confirmation:

Confirmatory testing typically completed within 48–72 hours after initial positive screen.

Result Notification:

Medical review officer notifies employer per policy and privacy rules promptly.

Retention Start Date:

Retention period begins on the execution date or the test date, as specified.

Key processing milestones from issuance to retention

Track these sequential milestones to ensure timely collection, review, and recordkeeping for each consented test.

01

Policy Issued

Employer distributes policy and consent to the employee for review and signature.

02

Consent Signed

Employee signs and date-stamps the consent before specimen collection.

03

Test Collected

Certified collector records chain-of-custody and ships sample to the lab.

04

Results Finalized

Medical reviewer returns final report and HR applies policy outcomes.

Common mistakes that weaken consent and testing evidence

  • Delivering the form at collection time with no review period, which can lead to claims of coerced consent and procedural challenge.
  • Using vague consent wording that fails to specify testing types or how results will be used, creating ambiguity in disciplinary decisions.
  • Failing to document chain-of-custody or using unsecured storage for signed forms and test results, which undermines evidentiary value in disputes.
  • Omitting privacy notices or a BAA when PHI is involved, exposing the employer to HIPAA or state privacy compliance issues.

Legal and operational risks of improper consents

Employment Liability: Wrongful termination claims
Privacy Violations: HIPAA or state privacy fines
Evidence Loss: Chain-of-custody gaps weaken defense
Union Grievances: Contractual disputes and arbitration
Regulatory Scrutiny: OSHA or agency inquiries
Reputational Harm: Employee morale and public exposure

How the Employee Drug Policy Consent differs from related forms

Compare scope, privacy implications, and who signs to avoid using the wrong template for a given purpose.

Criteria Employee Drug Policy Consent Medical Release
Consent Scope workplace testing clinical treatment
PHI Included minimal typical often includes detailed phi
Signing Parties employee and employer patient and provider
Use in Adverse Action employment decisions medical care only

Frequently asked questions about Employee Drug Policy Consent

Answers to common compliance and practical questions about drafting, collecting, and storing consents.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users